Kazakhstan Implements Ban on E-Cigarette Sales and Distribution

Regulations by 2FIRSTS.ai

Apr.22.2024

Kazakhstan Implements Ban on E-Cigarette Sales and Distribution

Kazakhstan bans e-cigarette sales and distribution, with violators facing up to five years in prison, according to reports.

According to a report from the Middle East Media Trend Agency on April 19th, Kazakhstan has implemented regulations banning the sale and distribution of e-cigarettes. This news was reported on the official website of Kazakhstan's president, Aqorda.

The President of Kazakhstan, Kassym-Jomart Tokayev, has signed a law titled "On Introducing Amendments and Additions to Certain Health Regulations of the Republic of Kazakhstan".

The website Acorida stated that this law, which will take effect 60 days after being officially announced, prohibits the sale and distribution of non-tobacco products, e-cigarettes, flavors, and e-liquids, as well as their advertisements.

Earlier this year, the Kazakhstan Parliament passed legislation that restricts the use of tobacco products. As a result, the law imposes restrictions on the import, production, sale, and distribution of e-cigarette devices.

Those who engage in such activities will face criminal responsibility: selling e-cigarettes may lead to a maximum of 50 days in prison; importing and distributing may result in up to two years in prison; and for criminal organizations committing large-scale or repeat offenses, the maximum sentence could be five years in prison.

References:

[1] Kazakhstan Bans Vape Sales And Distribution

Also Read:

[1] Brazilian Health Regulatory Agency Maintains Ban on E-Cigarettes

[2] Philippine Tobacco Industry Supports Proposal to Ban Disposable E-Cigarettes

[3] Mississippi House Considers Bill to Ban E-Cigarette Sales

#Legislation #E-cigarettes #Asia #Kazakhstan

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways

2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.

Oct.13

Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute

Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.

Oct.15 by 2FIRSTS.ai

Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia

Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.